EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

State of the Art in the Standardization of Stromal Vascular Fraction Processing

Martina Cremona, Matteo Gallazzi iD, Giulio Rusconi iD, Luca Mariotta iD, Mauro Gola, Gianni Soldati

Biomolecules · 30.01.2025 · 15 (2) · 199

DOI: 10.3390/biom15020199 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 30.01.2025. Verfasst von Martina Cremona und 5 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Stem Cell Foundation, 6900 Lugano, Switzerland. Hauptthemen laut MEDLINE: Adipose Tissue, Stromal Cells, Cell Separation, Mesenchymal Stem Cells. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stromal Vascular Fraction (SVF) has gained significant attention in clinical applications due to its regenerative and anti-inflammatory properties. Initially identified decades ago, SVF is derived from adipose tissue and has been increasingly utilized in a variety of therapeutic settings. The isolation and processing protocols for SVF have evolved substantially, particularly after its classification as an Advanced Therapy Medicinal Product (ATMP), which mandates adherence to Good Manufacturing Practices to ensure sterility and product quality. Despite the progress, few studies over the last decade have focused on the standardization of SVF processing. Recent advances, driven by the potential of SVF and its derived products such as Adipose-derived Stem Cells, have prompted the development of improved isolation strategies aimed at enhancing their therapeutic and regenerative efficacy. Notable progress includes the advent of automated processing systems, which reduce technical errors, minimize variability, and improve reproducibility across laboratories. These developments, along with the establishment of more precise protocols and guidelines, have enhanced the consistency and clinical applicability of SVF-based therapies. This review discusses the key aspects of SVF isolation and processing, highlighting the efforts to standardize the procedure and ensure the reliability of SVF products for clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adipose TissueStromal CellsCell SeparationMesenchymal Stem CellsHumansAnimals

Stichwörter der Autor:innen

GMPStromal Vascular Fractionadipose tissueadipose tissue processingcryopreservationquality controls

Autor:innen und Institutionen

  • Swiss Stem Cell Foundation, 6900 Lugano, Switzerland.
  • Swiss Stem Cells Biotech AG, 8008 Zürich, Switzerland.

ORCID-Profile: Matteo Gallazzi, Giulio Rusconi, Luca Mariotta

Zitieren

APA

Cremona, M., Gallazzi, M., Rusconi, G., Mariotta, L., Gola, M., & Soldati, G. (2025). State of the Art in the Standardization of Stromal Vascular Fraction Processing. Biomolecules, 15(2), 199. https://doi.org/10.3390/biom15020199

Vancouver

Cremona M, Gallazzi M, Rusconi G, Mariotta L, Gola M, Soldati G. State of the Art in the Standardization of Stromal Vascular Fraction Processing. Biomolecules. 2025;15(2):199. doi:10.3390/biom15020199

BibTeX
@article{Cremona2025,
  author = {Cremona, Martina and Gallazzi, Matteo and Rusconi, Giulio and Mariotta, Luca and Gola, Mauro and Soldati, Gianni},
  title = {State of the Art in the Standardization of Stromal Vascular Fraction Processing},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {2},
  pages = {199},
  doi = {10.3390/biom15020199}
}
Kostenlos starten →